T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.62B |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$1.61B |
| 3 |
Amazon
AMZN
|
+$1.18B |
| 4 |
Lam Research
LRCX
|
+$1.17B |
| 5 |
Las Vegas Sands
LVS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Yum! Brands
YUM
|
+$1.4B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Tesla
TSLA
|
+$1.13B |
| 4 |
JPMorgan Chase
JPM
|
+$1.11B |
| 5 |
Morgan Stanley
MS
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 15.3% |
| 4 | Consumer Discretionary | 15.25% |
| 5 | Communication Services | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
ManpowerGroup
MAN
$2.72B
| $9.36M | ﹤0.01% |
108,712
+914
| +0.8% | +$89.7K |
|
1352
TripAdvisor
TRIP
$1.27B
| $9.33M | ﹤0.01% |
167,405
-23,700
| -12% | -$1.13M |
|
|
AMRN
1353
Amarin Corp
AMRN
$296M
| $9.31M | ﹤0.01% |
150,610
+50,190
| +50% | +$3.11M |
|
1354
Viavi Solutions
VIAV
$10.5B
| $9.25M | ﹤0.01% |
903,585
+216,182
| +31% | +$2.14M |
|
|
CBAY
1355
DELISTED
Cymabay Therapeutics
CBAY
| $9.22M | ﹤0.01% |
687,277
-12,823
| -2% | -$160K |
|
1356
Rocket Pharmaceuticals
RCKT
$363M
| $9.17M | ﹤0.01% |
467,120
-17,885
| -4% | -$338K |
|
1357
Scholar Rock
SRRK
$6.39B
| $9.16M | ﹤0.01% |
+587,331
| New | +$11M |
|
1358
Xerox
XRX
$407M
| $9.14M | ﹤0.01% |
380,910
| – | – |
|
1359
Williams-Sonoma
WSM
$28.4B
| $9.04M | ﹤0.01% |
294,600
+11,114
| +4% | +$298K |
|
|
TVRD
1360
Tvardi Therapeutics
TVRD
$23.6M
| $9.04M | ﹤0.01% |
13,115
-198
| -1% | -$101K |
|
|
AMAG
1361
DELISTED
AMAG Pharmaceuticals
AMAG
| $9.04M | ﹤0.01% |
463,661
+196,249
| +73% | +$4.34M |
|
1362
ON Semiconductor
ON
$32B
| $8.98M | ﹤0.01% |
404,112
-7,524
| -2% | -$182K |
|
1363
Fate Therapeutics
FATE
$298M
| $8.95M | ﹤0.01% |
789,096
-173,677
| -18% | -$1.91M |
|
1364
H&R Block
HRB
$6.81B
| $8.83M | ﹤0.01% |
387,772
| – | – |
|
1365
Badger Meter
BMI
$3.79B
| $8.82M | ﹤0.01% |
197,405
-544,853
| -73% | -$24.1M |
|
1366
Dell
DELL
$317B
| $8.78M | ﹤0.01% |
369,807
+3,538
| +1% | +$78.2K |
|
1367
BHP
BHP
$220B
| $8.75M | ﹤0.01% |
196,076
+14,804
| +8% | +$641K |
|
1368
Ternium
TX
$10.6B
| $8.74M | ﹤0.01% |
251,056
-31,020
| -11% | -$1.16M |
|
|
IRCP
1369
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
| $8.72M | ﹤0.01% |
1,208,960
-92,111
| -7% | -$822K |
|
1370
Markel Group
MKL
$22.9B
| $8.47M | ﹤0.01% |
7,807
+261
| +3% | +$295K |
|
1371
Liberty Media Series C
FWONK
$26.3B
| $8.39M | ﹤0.01% |
233,669
+32,160
| +16% | +$981K |
|
|
ASRT
1372
DELISTED
Assertio
ASRT
| $8.32M | ﹤0.01% |
20,799
+711
| +4% | +$289K |
|
1373
Olin
OLN
$2.16B
| $8.29M | ﹤0.01% |
288,479
+60,201
| +26% | +$1.87M |
|
1374
Assembly Biosciences
ASMB
$625M
| $8.23M | ﹤0.01% |
17,491
+2,535
| +17% | +$1.34M |
|
|
CETV
1375
DELISTED
Central European Media Enterprises Ltd
CETV
| $8.18M | ﹤0.01% |
1,970,903
-1,418,549
| -42% | -$5.64M |
|
Similar funds
T. Rowe Price Associates's Q2 2018 Portfolio in Review
As of Q2 2018, T. Rowe Price Associates held 2,648 positions worth $654B, up 4% from $629B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2018 filing shows 98 new, 1,625 increased, 741 reduced and 68 closed positions. Its largest new stake was Evergy: 16,595,898 shares worth $932M. The largest sale was Yum! Brands, an estimated $1.4B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2018 buy was Evergy: 16,595,898 shares worth $932M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q2 2018, an estimated $1.62B increase.
- T. Rowe Price Associates's biggest Q2 2018 reduction was Yum! Brands, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited CSRA Inc. in Q2 2018, selling an estimated $912M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $654B portfolio in Q2 2018.
- T. Rowe Price Associates opened 98 new positions and closed 68 in Q2 2018.
- T. Rowe Price Associates's portfolio value rose 4% quarter-over-quarter to $654B.
Based on T. Rowe Price Associates's 13F filing for Q2 2018, filed 14 Aug 2018.